US Tech 100

19,181.60

-0.43%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

VLGC

Virologic (VLGC)

Virologic (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VLGC

1 2 Next >>

Date	Time	Source	Headline	Symbol	Company
09/07/2005	11:00AM	PR Newswire (US)	Monogram Biosciences to Present at Thomas Weisel Partners Healthcare Conference 2005 on September 9, 2005	NASDAQ:VLGC
09/06/2005	7:30AM	PR Newswire (US)	ViroLogic Changes Its Name to Monogram Biosciences	NASDAQ:VLGC	Virologic (MM)
09/01/2005	7:45AM	PR Newswire (US)	ViroLogic Appoints William J. Welch Senior Vice President and Chief Commercial Officer	NASDAQ:VLGC	Virologic (MM)
07/25/2005	7:45AM	PR Newswire (US)	ViroLogic Announces Second Quarter 2005 Financial Results Conference Call	NASDAQ:VLGC	Virologic (MM)
07/25/2005	7:30AM	PR Newswire (US)	ViroLogic Announces Second Quarter 2005 Financial Results	NASDAQ:VLGC	Virologic (MM)
07/19/2005	6:45PM	PR Newswire (US)	ViroLogic Announces Second Quarter 2005 Financial Results Conference Call	NASDAQ:VLGC	Virologic (MM)
07/06/2005	7:45AM	PR Newswire (US)	ViroLogic Announces Multi-Year Service Agreement With Schering-Plough to Support New HIV Drug Discovery and Development Efforts	NASDAQ:VLGC	Virologic (MM)
05/31/2005	8:00AM	PR Newswire (US)	ViroLogic to Present at Pacific Growth Equities 2005 Life Sciences Growth Conference	NASDAQ:VLGC	Virologic (MM)
05/20/2005	5:16PM	PR Newswire (US)	ViroLogic Added to the NASDAQ Biotechnology Index	NASDAQ:VLGC	Virologic (MM)
05/17/2005	8:01AM	PR Newswire (US)	ViroLogic's eTag System Demonstrates Potential Ability to Better Select Breast Cancer Patients for Therapy With Herceptin	NASDAQ:VLGC	Virologic (MM)
05/15/2005	8:00AM	PR Newswire (US)	Study Demonstrates ViroLogic's eTag System Can Measure Activated VEGF Receptor, Target for Anti-Angiogenic Treatments	NASDAQ:VLGC	Virologic (MM)
05/13/2005	6:35PM	PR Newswire (US)	Semi-Annual Changes to the NASDAQ Biotechnology Index	NASDAQ:VLGC	Virologic (MM)
05/04/2005	8:01AM	PR Newswire (US)	ViroLogic Announces Presentations on Its eTag Technology at the 2005 American Society of Clinical Oncology Annual Meeting (ASCO)	NASDAQ:VLGC	Virologic (MM)
05/02/2005	7:45AM	PR Newswire (US)	ViroLogic Announces First Quarter 2005 Financial Results Conference Call	NASDAQ:VLGC	Virologic (MM)
05/02/2005	7:30AM	PR Newswire (US)	ViroLogic Announces First Quarter 2005 Financial Results	NASDAQ:VLGC	Virologic (MM)
04/26/2005	6:58PM	PR Newswire (US)	ViroLogic Announces First Quarter 2005 Financial Results Conference Call	NASDAQ:VLGC	Virologic (MM)
04/22/2005	8:00AM	PR Newswire (US)	ViroLogic to Present at the Deutsche Bank Securities 30th Annual Health Care Conference on May 4, 2005	NASDAQ:VLGC	Virologic (MM)
04/07/2005	8:01AM	PR Newswire (US)	ViroLogic Announces Presentations at the 96th Annual Meeting of the American Association for Cancer Research (AACR)	NASDAQ:VLGC	Virologic (MM)
03/23/2005	7:00AM	PR Newswire (US)	ViroLogic to Present at the Lehman Brothers Eighth Annual Global Healthcare Conference on April 1, 2005	NASDAQ:VLGC	Virologic (MM)
03/21/2005	6:45AM	PR Newswire (US)	ViroLogic's Phenosense Assay Shown Superior to Virco's Antivirogram	NASDAQ:VLGC	Virologic (MM)
03/07/2005	6:00AM	PR Newswire (US)	ViroLogic and AstraZeneca to Conduct Iressa(R) Biomarker Study	NASDAQ:VLGC	Virologic (MM)
02/28/2005	6:45AM	PR Newswire (US)	Studies Highlight Utility of Virologic Assays in HIV Management at 12th Conference on Retroviruses and Opportunistic Infections	NASDAQ:VLGC	Virologic (MM)
02/22/2005	3:01PM	PR Newswire (US)	ViroLogic Announces Year End 2004 Financial Results	NASDAQ:VLGC	Virologic (MM)
02/14/2005	6:49PM	PR Newswire (US)	ViroLogic Announces Fourth Quarter and Year End 2004 Financial Results Conference Call	NASDAQ:VLGC	Virologic (MM)
02/14/2005	6:00AM	PR Newswire (US)	ViroLogic Assays Used to Characterize and Identify Potential Treatments for Virulent Multi-Drug Resistant Strain of HIV	NASDAQ:VLGC	Virologic (MM)
02/03/2005	6:45AM	PR Newswire (US)	ViroLogic Announces Three-Year Service Agreement With GlaxoSmithKline to Support New HIV Drug Discovery and Development Efforts	NASDAQ:VLGC	Virologic (MM)
01/27/2005	7:00AM	PR Newswire (US)	ViroLogic's eTAG(TM) System Demonstrates Potential Ability to Predict Treatment Outcomes for Colorectal Cancer Patients	NASDAQ:VLGC	Virologic (MM)
12/10/2004	12:31PM	PR Newswire (US)	ViroLogic and ACLARA Announce Stockholder Approval of Merger	NASDAQ:VLGC	Virologic (MM)
11/23/2004	1:15PM	PR Newswire (US)	ViroLogic to Present at Lazard's 1st Annual Life Sciences Conference on November 30, 2004	NASDAQ:VLGC	Virologic (MM)
11/15/2004	6:00AM	PR Newswire (US)	ViroLogic Announces Third Quarter 2004 Financial Results	NASDAQ:VLGC	Virologic (MM)